CIEL continued to focus on its HRTech and Consulting lines of business; as a result, the group contribution of these segments in the overall portfolio has increased to 41 per cent
Jubilant Pharma had invested $25 million in Sofie Biosciences in November 2020 and now plans to exit its investment completely
Why are DIIs holding such a high stake in Zee, which is beset with alleged governance issues? Perhaps they think Zee is a deep-value stock
Bhavin Pandya hopes this year will offer clarity around regulations on which games are allowed and which aren't
Neeyat is not a new management jargon to replace vision and mission, nor is it an attempt to nativise an Anglo-American concept in Bhartiya hues, but it is relevant for all businesses, big or small
The private sector has been going slow in adding fixed assets but squeezing out more
Balram Bhargava appointed as independent director on board
Hemant Bakshi, a former top Unilever executive, to lead Ola Mobility as CEO, with an aggressive growth focus
Net profit for the quarter beat Bloomberg consensus estimate of Rs 2,170.5 crore. But it trailed revenue estimates of Rs 42,774.5 crore
UK, is more of a structural problem and that's why we're doing the restructuring. But we expect the losses to be lower going forward as we start shutting down the blast furnaces
Margins under pressure; provisions rise sharply
Prior to joining Xoriant, he was the Chief Business Officer of Banking, Financial Services at LTIMindtree
About a week ago, Syngene International's share price declined by 3 per cent following UBS Global Research stock downgrade to sell
The Securities and Exchange Board of India (Sebi) continues to investigate allegations made by Hindenburg against the group. It has concluded 22 of the 24 investigations
The management estimates that capacity utilisation will improve to 80-85 per cent in Q4 from 77 per cent in Q3. Demand has recovered, except in the North
InCred Finance, a non-banking financial company (NBFC), said its loan portfolio is spread across segments such as consumer loans, education loans, and small and medium enterprise (SME) lending
After selling a 2 per cent stake in the fintech company, SoftBank's total shareholding has come down to 5.06 per cent. The company held a 13.24 per cent stake in February 2023
Its credit costs declined to 2.52 per cent from 2.67 per cent a year ago
The net income of the company stood at Rs 4,350 crore in Q3 FY24 as against Rs 3,573 crore in Q3 FY23, registering a jump of 21 per cent
Puravankara declared its earnings after market hours on Tuesday. Ahead of the earnings, its shares were down 6 per cent to close at Rs 220.90 on the Bombay Stock Exchange (BSE)